NCT03666663View on ClinicalTrials.gov

Sphenopalatine Ganglion Blocks RCT

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

July 8, 2021

Study Completion Date

July 8, 2021

Conditions
Migraine
Interventions
DRUG

Lidocaine

Nasal application using the Sphenocath device- cleared by FDA

DRUG

Bupivacaine

Nasal application using the Sphenocath device- cleared by FDA

DRUG

Ropivacaine

Nasal application using the Sphenocath device- cleared by FDA

DRUG

Placebo

Placebo Saline using the Sphenocath device- cleared by FDA

Trial Locations (1)

94115

UCSF Headache Center, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT03666663 - Sphenopalatine Ganglion Blocks RCT | Biotech Hunter | Biotech Hunter